Cargando…

Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias

Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dement...

Descripción completa

Detalles Bibliográficos
Autores principales: Fallon, Sean James, Plant, Olivia, Tabi, Younes A, Manohar, Sanjay G, Husain, Masud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404008/
https://www.ncbi.nlm.nih.gov/pubmed/37545547
http://dx.doi.org/10.1093/braincomms/fcad207
_version_ 1785085200998334464
author Fallon, Sean James
Plant, Olivia
Tabi, Younes A
Manohar, Sanjay G
Husain, Masud
author_facet Fallon, Sean James
Plant, Olivia
Tabi, Younes A
Manohar, Sanjay G
Husain, Masud
author_sort Fallon, Sean James
collection PubMed
description Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dementia with Lewy bodies patients were tested twice: once when taking rivastigmine as usual and once when they had missed one dose. In each session, they performed a suite of tasks (sustained attention, simple short-term recall, distractor resistance and manipulating the focus of attention) that allowed us to investigate the cognitive mechanisms through which rivastigmine affects attentional control. Consistent with previous literature, rivastigmine withdrawal significantly impaired attentional efficacy (quicker response latencies without a change in accuracy). However, it had no effects on cognitive control as assessed by the ability to withhold a response (inhibitory control). Worse short-term memory performance was also observed when patients were OFF rivastigmine, but these effects were delay and load independent, likely due to impaired visual attention. In contrast to previous studies that have examined the effects of dopamine withdrawal, cognitively complex tasks requiring control over the contents of working memory (ignoring, updating or shifting the focus of attention) were not significantly impaired by rivastigmine withdrawal. Cumulatively, these data support that the conclusion that cholinesterase inhibition has relatively specific and circumscribed—rather than global—effects on attention that may also affect performance on simple short-term memory tasks, but not when cognitive control over working memory is required. The results also indicate that the withdrawal of a single dose of rivastigmine is sufficient to reveal these impairments, demonstrating that cholinergic withdrawal can be an informative clinical as well as an investigative tool.
format Online
Article
Text
id pubmed-10404008
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104040082023-08-06 Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias Fallon, Sean James Plant, Olivia Tabi, Younes A Manohar, Sanjay G Husain, Masud Brain Commun Original Article Cholinesterase inhibitors are frequently used to treat cognitive symptoms in Lewy body dementias (Parkinson’s disease dementia and dementia with Lewy bodies). However, the selectivity of their effects remains unclear. In a novel rivastigmine withdrawal design, Parkinson’s disease dementia and dementia with Lewy bodies patients were tested twice: once when taking rivastigmine as usual and once when they had missed one dose. In each session, they performed a suite of tasks (sustained attention, simple short-term recall, distractor resistance and manipulating the focus of attention) that allowed us to investigate the cognitive mechanisms through which rivastigmine affects attentional control. Consistent with previous literature, rivastigmine withdrawal significantly impaired attentional efficacy (quicker response latencies without a change in accuracy). However, it had no effects on cognitive control as assessed by the ability to withhold a response (inhibitory control). Worse short-term memory performance was also observed when patients were OFF rivastigmine, but these effects were delay and load independent, likely due to impaired visual attention. In contrast to previous studies that have examined the effects of dopamine withdrawal, cognitively complex tasks requiring control over the contents of working memory (ignoring, updating or shifting the focus of attention) were not significantly impaired by rivastigmine withdrawal. Cumulatively, these data support that the conclusion that cholinesterase inhibition has relatively specific and circumscribed—rather than global—effects on attention that may also affect performance on simple short-term memory tasks, but not when cognitive control over working memory is required. The results also indicate that the withdrawal of a single dose of rivastigmine is sufficient to reveal these impairments, demonstrating that cholinergic withdrawal can be an informative clinical as well as an investigative tool. Oxford University Press 2023-07-27 /pmc/articles/PMC10404008/ /pubmed/37545547 http://dx.doi.org/10.1093/braincomms/fcad207 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Fallon, Sean James
Plant, Olivia
Tabi, Younes A
Manohar, Sanjay G
Husain, Masud
Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title_full Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title_fullStr Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title_full_unstemmed Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title_short Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
title_sort effects of cholinesterase inhibition on attention and working memory in lewy body dementias
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404008/
https://www.ncbi.nlm.nih.gov/pubmed/37545547
http://dx.doi.org/10.1093/braincomms/fcad207
work_keys_str_mv AT fallonseanjames effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias
AT plantolivia effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias
AT tabiyounesa effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias
AT manoharsanjayg effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias
AT husainmasud effectsofcholinesteraseinhibitiononattentionandworkingmemoryinlewybodydementias